AJJ Medtech Holdings Limited (SGX: 584)

Market Cap	6.01M
Revenue (ttm)	2.46M
Net Income (ttm)	-2.57M
Shares Out	1.50B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.0030 - 0.0070
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About AJJ Medtech Holdings

AJJ Medtech Holdings Limited provides providing MedTech integrated solutions to healthcare sector in Singapore. It supplies medical devices with complementary digital, artificial intelligence (AI), and robotics solutions to customers and supplying partners. The company offers in-vitro diagnostics, including point of call diagnostics with focus on at-home monitoring and diagnostics, including blood glucose monitoring system and single-use test kits, as well as laboratory diagnostics and biobanking solutions with focus on solutions on diagnostics...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1984
• Employees: 32
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 584

Financial Performance

In 2023, AJJ Medtech Holdings's revenue was 1.62 million, an increase of 170.97% compared to the previous year's 596,000. Losses were -2.53 million, -40.41% less than in 2022.